ResMed has estimated at its quarterly earnings release that in a high adoption case, GLP-1s will reduce its addressable market in 2050 from 1.4 billion to 1.2 billion patients (from around 1 billion today)
, L-, 3000 , 23
Novo Nordisk announced it will cut Ozempic and Wegovy list prices by up to 50% starting in 2027
Ingredients N-Acetyl Carnitine, Coating (Stabiliser (Hydroxypropyl Methyl Cellulose), Bulking Agent (Gellan Gum), Colour (Iron Oxides and Hydroxides)), L-Theanine, Anti-Caking Agent (Silicon Dioxide), L-Methionine, Anti-Caking Agent (Magnesium Salts of Fatty Acids), Thickener (Microcrystalline Cellulose)
Always consult your healthcare provider or registered dietitian for personalized guidance on your GLP-1 journey
Mitochondrial iron overload: causes and consequences